John F Crowley Insider Trading $FOLD AMICUS THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John F Crowley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John F Crowley. John F Crowley is Chairman & CEO in AMICUS THERAPEUTICS INC ($FOLD) and Chairman, President & CEO in AMICUS THERAPEUTICS INC ($FOLD) and Executive Chairman in AMICUS THERAPEUTICS INC ($FOLD) and President & CEO in AMICUS THERAPEUTICS INC ($FOLD) and President and CEO in AMICUS THERAPEUTICS INC ($FOLD) and Director in Intellia Therapeutics, Inc. ($NTLA).
John F Crowley in AMICUS THERAPEUTICS, INC.
Trading Symbol: FOLDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John F Crowley: Chairman & CEO, Executive Chairman, Chairman, President & CEO, President and CEO, President & CEO
Holdings: 905,287 shares
Current Value: $5,449,828
Latest Transaction: Jun 09 2021
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John F Crowley in AMICUS THERAPEUTICS, INC.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 506 | 5,166 | 0 | |
Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 65,075 | 664,416 | 506 | |
Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.51 | 506 | 6,836 | 328,001 | 328.5 K to 328 K (-0.15 %) |
Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.51 | 506 | 6,836 | 358,507 | 358 K to 358.5 K (+0.14 %) |
Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.51 | 65,075 | 878,929 | 328,001 | 393.1 K to 328 K (-16.56 %) |
Dec 21 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.51 | 65,075 | 878,929 | 393,076 | 328 K to 393.1 K (+19.84 %) |
Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 6,991 | 71,378 | 65,581 | |
Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 5,215 | 53,245 | 0 | |
Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.52 | 12,206 | 164,973 | 328,001 | 340.2 K to 328 K (-3.59 %) |
Dec 13 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.52 | 12,206 | 164,973 | 340,207 | 328 K to 340.2 K (+3.72 %) |
Dec 06 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.21 | 47,213 | 482,045 | 77,787 | |
Dec 06 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.61 | 47,213 | 642,734 | 328,001 | 375.2 K to 328 K (-12.58 %) |
Dec 06 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.61 | 47,213 | 642,734 | 375,214 | 328 K to 375.2 K (+14.39 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 19,013 | 67,116 | 20,508 | |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 52,722 | 186,109 | 39,521 | |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.76 | 19,013 | 280,544 | 328,001 | 347 K to 328 K (-5.48 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.76 | 19,013 | 280,544 | 347,014 | 328 K to 347 K (+5.80 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 52,722 | 777,650 | 328,001 | 380.7 K to 328 K (-13.85 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 52,722 | 777,650 | 380,723 | 328 K to 380.7 K (+16.07 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 47,135 | 166,387 | 92,243 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 22,160 | 78,225 | 139,378 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 192,133 | 612,904 | 20,972 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 2.52 | 165,000 | 415,800 | 0 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 3,462 | 12,221 | 161,538 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.38 | 13,622 | 59,664 | 136,378 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 5,783 | 37,300 | 131,024 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 47,135 | 695,241 | 328,001 | 375.1 K to 328 K (-12.56 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 47,135 | 695,241 | 375,136 | 328 K to 375.1 K (+14.37 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 22,160 | 326,867 | 328,001 | 350.2 K to 328 K (-6.33 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 22,160 | 326,867 | 350,161 | 328 K to 350.2 K (+6.76 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.25 | 380,000 | 5,414,810 | 328,001 | 708 K to 328 K (-53.67 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.25 | 380,000 | 5,414,810 | 708,001 | 328 K to 708 K (+115.85 %) |
Sep 28 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | C | 3.19 | 1,395 | 4,450 | 213,105 | |
Sep 28 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | P | 14.36 | 1,395 | 20,032 | 328,001 | 326.6 K to 328 K (+0.43 %) |
Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 8.79 | 5,005 | 43,994 | 326,606 | 331.6 K to 326.6 K (-1.51 %) |
Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 5.13 | 282,485 | 1,449,148 | 282,485 | |
Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 203,252 | 0 | 331,611 | 128.4 K to 331.6 K (+158.35 %) |
Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 7.93 | 83,333 | 660,831 | 83,333 | |
Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 41,667 | 0 | 128,359 | 86.7 K to 128.4 K (+48.06 %) |
May 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 6.59 | 5,000 | 32,950 | 91,692 | 86.7 K to 91.7 K (+5.77 %) |
Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 11.74 | 250,000 | 2,935,000 | 250,000 | |
Oct 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 13,193 | 85,095 | 136,807 | |
Oct 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 13,193 | 85,095 | 96,692 | 83.5 K to 96.7 K (+15.80 %) |
Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 16,025 | 95,509 | 103,975 | |
Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 16.00 | 16,025 | 256,400 | 83,499 | 99.5 K to 83.5 K (-16.10 %) |
Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 16.00 | 16,025 | 256,400 | 99,524 | 83.5 K to 99.5 K (+19.19 %) |
Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.16 | 142,250 | 591,760 | 0 | |
Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.16 | 7,750 | 32,240 | 142,250 | |
Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.03 | 142,250 | 2,137,676 | 83,499 | 225.7 K to 83.5 K (-63.01 %) |
Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 15.03 | 142,250 | 2,137,676 | 225,749 | 83.5 K to 225.7 K (+170.36 %) |
Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.01 | 7,750 | 116,315 | 83,499 | 91.2 K to 83.5 K (-8.49 %) |
Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 15.01 | 7,750 | 116,315 | 91,249 | 83.5 K to 91.2 K (+9.28 %) |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 2.81 | 55,000 | 154,550 | 0 | |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.01 | 55,000 | 715,550 | 83,499 | 138.5 K to 83.5 K (-39.71 %) |
Jun 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 13.01 | 55,000 | 715,550 | 138,499 | 83.5 K to 138.5 K (+65.87 %) |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 15.96 | 230,000 | 3,670,800 | 230,000 | |
Apr 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.33 | 11,678 | 62,185 | 0 | |
Apr 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.00 | 11,678 | 140,136 | 83,499 | 95.2 K to 83.5 K (-12.27 %) |
Apr 13 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 12.00 | 11,678 | 140,136 | 95,177 | 83.5 K to 95.2 K (+13.99 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.33 | 268,322 | 1,428,815 | 0 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.49 | 268,322 | 3,082,242 | 83,499 | 351.8 K to 83.5 K (-76.27 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 11.49 | 268,322 | 3,082,242 | 351,821 | 83.5 K to 351.8 K (+321.35 %) |
Apr 03 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 0.64 | 49,931 | 31,956 | 0 | |
Apr 03 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 0.64 | 49,931 | 31,956 | 59,798 | 9.9 K to 59.8 K (+506.04 %) |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 6.45 | 150,000 | 967,500 | 150,000 | |
Aug 15 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | P | 4.20 | 10,000 | 42,000 | 109,867 | 99.9 K to 109.9 K (+10.01 %) |
Jun 21 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Executive Chairman | Buy | P | 6.04 | 20,000 | 120,800 | 99,867 | 79.9 K to 99.9 K (+25.04 %) |
Jun 21 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Executive Chairman | Gift | G | 0.00 | 10,000 | 0 | 79,867 | 89.9 K to 79.9 K (-11.13 %) |
Feb 03 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Gift | G | 0.00 | 5,000 | 0 | 66,634 | 71.6 K to 66.6 K (-6.98 %) |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Option Exercise | A | 5.96 | 120,000 | 715,200 | 120,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Option Exercise | A | 2.81 | 55,000 | 154,550 | 55,000 | |
Mar 03 2010 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Option Exercise | P | 4.43 | 11,898 | 52,708 | 11,898 | |
Mar 03 2010 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Buy | P | 3.69 | 11,898 | 43,904 | 71,634 | 59.7 K to 71.6 K (+19.92 %) |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | A | 4.16 | 150,000 | 624,000 | 150,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Gift | G | 0.00 | 10,000 | 0 | 59,736 | 69.7 K to 59.7 K (-14.34 %) |
Jul 16 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.29 | 3,500 | 36,001 | 69,736 | 73.2 K to 69.7 K (-4.78 %) |
Jul 16 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.69 | 6,500 | 69,472 | 73,236 | 79.7 K to 73.2 K (-8.15 %) |
Jul 16 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.28 | 4,748 | 48,819 | 79,736 | 84.5 K to 79.7 K (-5.62 %) |
Jul 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.09 | 800 | 8,069 | 84,484 | 85.3 K to 84.5 K (-0.94 %) |
Jul 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.06 | 200 | 2,011 | 85,284 | 85.5 K to 85.3 K (-0.23 %) |
Jul 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.24 | 1,652 | 16,918 | 85,484 | 87.1 K to 85.5 K (-1.90 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 12.49 | 100 | 1,249 | 87,136 | 87.2 K to 87.1 K (-0.11 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.09 | 971 | 10,766 | 87,236 | 88.2 K to 87.2 K (-1.10 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.37 | 11,829 | 122,667 | 88,207 | 100 K to 88.2 K (-11.82 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.69 | 412 | 4,814 | 100,036 | 100.4 K to 100 K (-0.41 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.15 | 5,788 | 64,525 | 100,448 | 106.2 K to 100.4 K (-5.45 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.59 | 10,400 | 120,494 | 106,236 | 116.6 K to 106.2 K (-8.92 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.42 | 3,100 | 32,308 | 116,636 | 119.7 K to 116.6 K (-2.59 %) |
Mar 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | M | 5.33 | 1,000 | 5,325 | 89,000 | |
Mar 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Buy | M | 5.33 | 1,000 | 5,325 | 119,736 | 118.7 K to 119.7 K (+0.84 %) |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | A | 10.36 | 103,500 | 1,072,260 | 103,500 | |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.29 | 5,000 | 51,450 | 5,200 | 10.2 K to 5.2 K (-49.02 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.27 | 5,000 | 51,335 | 18,033 | 23 K to 18 K (-21.71 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | M | 5.33 | 10,000 | 53,250 | 90,000 | |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | M | 0.64 | 30,000 | 19,125 | 49,931 | |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Buy | M | 5.33 | 10,000 | 53,250 | 118,736 | 108.7 K to 118.7 K (+9.20 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Buy | M | 0.64 | 30,000 | 19,125 | 108,736 | 78.7 K to 108.7 K (+38.10 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.76 | 1,200 | 17,708 | 10,200 | 11.4 K to 10.2 K (-10.53 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.75 | 1,100 | 16,228 | 23,033 | 24.1 K to 23 K (-4.56 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.98 | 1,900 | 28,453 | 11,400 | 13.3 K to 11.4 K (-14.29 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.96 | 1,800 | 26,928 | 24,133 | 25.9 K to 24.1 K (-6.94 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.06 | 1,300 | 19,582 | 13,300 | 14.6 K to 13.3 K (-8.90 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.13 | 1,300 | 19,669 | 25,933 | 27.2 K to 25.9 K (-4.77 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.08 | 600 | 9,050 | 14,600 | 15.2 K to 14.6 K (-3.95 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.08 | 800 | 12,063 | 27,233 | 28 K to 27.2 K (-2.85 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.74 | 1,200 | 16,490 | 15,200 | 16.4 K to 15.2 K (-7.32 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.74 | 1,300 | 17,866 | 28,033 | 29.3 K to 28 K (-4.43 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.85 | 1,300 | 17,999 | 16,400 | 17.7 K to 16.4 K (-7.34 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.83 | 1,200 | 16,601 | 29,333 | 30.5 K to 29.3 K (-3.93 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.79 | 1,200 | 16,542 | 17,700 | 18.9 K to 17.7 K (-6.35 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.75 | 1,300 | 17,869 | 30,533 | 31.8 K to 30.5 K (-4.08 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.82 | 1,300 | 17,967 | 18,900 | 20.2 K to 18.9 K (-6.44 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.75 | 1,300 | 17,871 | 31,833 | 33.1 K to 31.8 K (-3.92 %) |
Aug 28 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.61 | 13,333 | 181,475 | 0 | 13.3 K to 0 (-100.00 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.22 | 3,000 | 45,648 | 20,200 | 23.2 K to 20.2 K (-12.93 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.27 | 3,200 | 48,858 | 33,133 | 36.3 K to 33.1 K (-8.81 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.43 | 2,000 | 30,858 | 23,200 | 25.2 K to 23.2 K (-7.94 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.42 | 1,800 | 27,747 | 36,333 | 38.1 K to 36.3 K (-4.72 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.24 | 300 | 3,372 | 25,200 | 25.5 K to 25.2 K (-1.18 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.22 | 400 | 4,488 | 25,500 | 25.9 K to 25.5 K (-1.54 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.16 | 135 | 1,507 | 25,900 | 26 K to 25.9 K (-0.52 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.15 | 65 | 725 | 26,035 | 26.1 K to 26 K (-0.25 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.70 | 100 | 1,070 | 26,100 | 26.2 K to 26.1 K (-0.38 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.26 | 200 | 2,252 | 38,133 | 38.3 K to 38.1 K (-0.52 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.24 | 208 | 2,338 | 38,333 | 38.5 K to 38.3 K (-0.54 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.23 | 100 | 1,123 | 38,541 | 38.6 K to 38.5 K (-0.26 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.22 | 300 | 3,366 | 38,641 | 38.9 K to 38.6 K (-0.77 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.19 | 92 | 1,029 | 38,941 | 39 K to 38.9 K (-0.24 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 200 | 2,150 | 39,033 | 39.2 K to 39 K (-0.51 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.69 | 100 | 1,069 | 39,233 | 39.3 K to 39.2 K (-0.25 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.03 | 200 | 2,206 | 26,200 | 26.4 K to 26.2 K (-0.76 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.89 | 100 | 1,089 | 26,400 | 26.5 K to 26.4 K (-0.38 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 300 | 3,225 | 26,500 | 26.8 K to 26.5 K (-1.12 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.73 | 100 | 1,073 | 26,800 | 26.9 K to 26.8 K (-0.37 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.03 | 200 | 2,206 | 39,333 | 39.5 K to 39.3 K (-0.51 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 400 | 4,300 | 39,533 | 39.9 K to 39.5 K (-1.00 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.73 | 200 | 2,146 | 39,933 | 40.1 K to 39.9 K (-0.50 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.11 | 700 | 7,777 | 26,900 | 27.6 K to 26.9 K (-2.54 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.09 | 209 | 2,318 | 27,600 | 27.8 K to 27.6 K (-0.75 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.08 | 200 | 2,216 | 27,809 | 28 K to 27.8 K (-0.71 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.06 | 100 | 1,106 | 28,009 | 28.1 K to 28 K (-0.36 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.04 | 91 | 1,005 | 28,109 | 28.2 K to 28.1 K (-0.32 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.92 | 100 | 1,092 | 28,200 | 28.3 K to 28.2 K (-0.35 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.79 | 23 | 248 | 28,300 | 28.3 K to 28.3 K (-0.08 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.78 | 600 | 6,468 | 28,323 | 28.9 K to 28.3 K (-2.07 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.76 | 100 | 1,076 | 28,923 | 29 K to 28.9 K (-0.34 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 100 | 1,075 | 29,023 | 29.1 K to 29 K (-0.34 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.73 | 300 | 3,219 | 29,123 | 29.4 K to 29.1 K (-1.02 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.72 | 477 | 5,113 | 29,423 | 29.9 K to 29.4 K (-1.60 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.63 | 100 | 1,063 | 29,900 | 30 K to 29.9 K (-0.33 %) |